“Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Final Analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s176. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2001.